| Mark T Claus, MD | |
|
35 Pearl St, Suite 300, Brockton, MA 02301-2866 | |
| (508) 584-6300 | |
| (508) 580-4664 |
| Full Name | Mark T Claus |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 42 Years |
| Location | 35 Pearl St, Brockton, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518910686 | NPI | - | NPPES |
| 3036529 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | 59634 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Milford Regional Medical Center | Milford, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Asthma And Allergy Physicians Llc | 7012950801 | 5 |
News Archive
A paper published in the current issue of psychotherapy and psychosomatics provides data concerned with the appropriateness of a diagnosis of post-traumatic stress disorder in women with a diagnosis of cancer.
AbbVie, a global biopharmaceutical company, today announced that 91 percent (n=20/22) of genotype 1 (GT1) chronic hepatitis C virus (HCV) infected patients who failed previous therapy with direct-acting antivirals (DAAs) achieved SVR12 with 12 weeks of ABT-493 and ABT-530 with ribavirin (RBV) in the primary intent-to-treat analysis.
US-based researchers – at Colorado State University and the Northern Arizona University – have discovered that disease-causing ticks are finding their way onto beachfront properties, including infestations in woodlands and beaches around North California.
In recent years access to drugs and vaccines has been increasing in many African countries, but the systems for monitoring treatment effects and reporting side-effects require further development. Karolinska Institutet will now lead an international collaboration project on pharmacovigilance - drugs safety - in four countries in East Africa.
A unique study at Children's Hospital Los Angeles of newborns treated with hypothermia for hypoxic-ischemic encephalopathy (HIE) - a condition that occurs when the brain is deprived of an adequate oxygen supply - confirms its neuroprotective effects on the brain.
› Verified 7 days ago
| Entity Name | Asthma & Allergy Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376586354 PECOS PAC ID: 7012950801 Enrollment ID: O20050602000741 |
News Archive
A paper published in the current issue of psychotherapy and psychosomatics provides data concerned with the appropriateness of a diagnosis of post-traumatic stress disorder in women with a diagnosis of cancer.
AbbVie, a global biopharmaceutical company, today announced that 91 percent (n=20/22) of genotype 1 (GT1) chronic hepatitis C virus (HCV) infected patients who failed previous therapy with direct-acting antivirals (DAAs) achieved SVR12 with 12 weeks of ABT-493 and ABT-530 with ribavirin (RBV) in the primary intent-to-treat analysis.
US-based researchers – at Colorado State University and the Northern Arizona University – have discovered that disease-causing ticks are finding their way onto beachfront properties, including infestations in woodlands and beaches around North California.
In recent years access to drugs and vaccines has been increasing in many African countries, but the systems for monitoring treatment effects and reporting side-effects require further development. Karolinska Institutet will now lead an international collaboration project on pharmacovigilance - drugs safety - in four countries in East Africa.
A unique study at Children's Hospital Los Angeles of newborns treated with hypothermia for hypoxic-ischemic encephalopathy (HIE) - a condition that occurs when the brain is deprived of an adequate oxygen supply - confirms its neuroprotective effects on the brain.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark T Claus, MD 35 Pearl St, Suite 300, Brockton, MA 02301-2866 Ph: (508) 584-6300 | Mark T Claus, MD 35 Pearl St, Suite 300, Brockton, MA 02301-2866 Ph: (508) 584-6300 |
News Archive
A paper published in the current issue of psychotherapy and psychosomatics provides data concerned with the appropriateness of a diagnosis of post-traumatic stress disorder in women with a diagnosis of cancer.
AbbVie, a global biopharmaceutical company, today announced that 91 percent (n=20/22) of genotype 1 (GT1) chronic hepatitis C virus (HCV) infected patients who failed previous therapy with direct-acting antivirals (DAAs) achieved SVR12 with 12 weeks of ABT-493 and ABT-530 with ribavirin (RBV) in the primary intent-to-treat analysis.
US-based researchers – at Colorado State University and the Northern Arizona University – have discovered that disease-causing ticks are finding their way onto beachfront properties, including infestations in woodlands and beaches around North California.
In recent years access to drugs and vaccines has been increasing in many African countries, but the systems for monitoring treatment effects and reporting side-effects require further development. Karolinska Institutet will now lead an international collaboration project on pharmacovigilance - drugs safety - in four countries in East Africa.
A unique study at Children's Hospital Los Angeles of newborns treated with hypothermia for hypoxic-ischemic encephalopathy (HIE) - a condition that occurs when the brain is deprived of an adequate oxygen supply - confirms its neuroprotective effects on the brain.
› Verified 7 days ago
Michael Lawrence, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 35 Pearl St, Suite 300, Brockton, MA 02301 Phone: 508-584-6300 Fax: 508-580-4664 |